ATNM Stock Analysis: Buy, Sell, or Hold?
ATNM - Actinium Pharmaceuticals, Inc
$1.22
0.06 (5.17%)
▲
5d:
-3.94%
30d:
-10.29%
90d:
-14.08%
BUY
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 13, 2026
Get Alerted When ATNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ATNM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ATNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ATNM shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ATNM is currently trading at $1.22, which is considered oversold relative to its 30-day fair value range of $1.25 to $1.42.
Technical Outlook: Technically, ATNM is in a downtrend. Immediate support is located at $1.15, while resistance sits at $1.38. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ATNM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+309.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ATNM is in a downtrend. Immediate support is located at $1.15, while resistance sits at $1.38. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ATNM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+309.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.25 -
$1.42
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 309.8% below Wall St target ($5.00)
Fair Price Analysis
30-Day Fair Range
$1.25 -
$1.42
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$1.38
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.54
Wall Street Target
$5.00
(+309.8%)
Revenue Growth (YoY)
-100.0%
Last updated: February 03, 2026 9:13 AM ET
Data refreshes hourly during market hours. Next update: 10:13 AM
Data refreshes hourly during market hours. Next update: 10:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATNM showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 61 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$7 | 61 BUY |
